Re-thinking the Etiological Framework of Neurodegeneration
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are among the leading causes of disability and death worldwide. The disease-related socioeconomic burden is expected to increase with the steadily increasing life expectancy. In spite of decades of clinical and basic research, most strategies designed to manage degenerative brain diseases are palliative. This is not surprising as neurodegeneration progresses "silently" for decades before symptoms are noticed. Importantly, conceptual models with heuristic value used to study neurodegeneration have been constructed retrospectively, based on signs and symptoms already present in affected patients; a circumstance that may confound causes and consequences. Hence, innovative, paradigm-shifting views of the etiology of these diseases are necessary to enable their timely prevention and treatment. Here, we outline four alternative views, not mutually exclusive, on different etiological paths toward neurodegeneration. First, we propose neurodegeneration as being a secondary outcome of a primary cardiovascular cause with vascular pathology disrupting the vital homeostatic interactions between the vasculature and the brain, resulting in cognitive impairment, dementia, and cerebrovascular events such as stroke. Second, we suggest that the persistence of senescent cells in neuronal circuits may favor, together with systemic metabolic diseases, neurodegeneration to occur. Third, we argue that neurodegeneration may start in response to altered body and brain trophic interactions established via the hardwire that connects peripheral targets with central neuronal structures or by means of extracellular vesicle (EV)-mediated communication. Lastly, we elaborate on how lifespan body dysbiosis may be linked to the origin of neurodegeneration. We highlight the existence of bacterial products that modulate the gut-brain axis causing neuroinflammation and neuronal dysfunction. As a concluding section, we end by recommending research avenues to investigate these etiological paths in the future. We think that this requires an integrated, interdisciplinary conceptual research approach based on the investigation of the multimodal aspects of physiology and pathophysiology. It involves utilizing proper conceptual models, experimental animal units, and identifying currently unused opportunities derived from human data. Overall, the proposed etiological paths and experimental recommendations will be important guidelines for future cross-discipline research to overcome the translational roadblock and to develop causative treatments for neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×
“The disruption of the adjustment mechanisms by a sustained increase in the blood pressure has been linked to different neurodegenerative diseases such as stroke (MacMahon et al., 1990).”
BackgroundGorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“…endothelial tight junction molecules, has been observed in several neurodegenerative diseases, including AD, PD, amyotrophic lateral sclerosis (ALS), and Huntington’s disease (Zlokovic, 2008; Chao et al., 2009; Duran-Vilaregut et al., 2009; Henkel et al., 2009; Kalaria, 2010; Alvarez et al., 2011).”
BackgroundBlood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Colonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“Since aging has been linked to the accumulation of senescent cells (van Deursen, 2014; Calcinotto et al., 2019), we speculate that cellular senescence may contribute to the outcome after stroke.”
BackgroundThe Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137
The glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Analysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924 · cited 1×
“We did not cover here genetic components as risk factors for neurodegeneration, a comprehensive analysis of which can be found elsewhere (Brainstorm et al., 2018).”
BackgroundInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“Although MS is regarded as a classical autoimmune disease, it has been hypothesized that the driver of the autoreactive immune response in MS is actually a primary neurodegenerative process (Trapp and Nave, 2008).”
BackgroundDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., & Giuffrida Stella, A. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2214 · Cited by 1,543 · cited 1×
“Abnormal NO signaling is likely to contribute to a variety of neurodegenerative pathologies such as excitotoxicity following stroke, multiple sclerosis (MS), Alzheimer’s disease (AD), and Parkinson’s disease (PD) (Calabrese et al., 2007).”
BackgroundInteractions between the microbiota and pathogenic bacteria in the gut
Bäumler, A. J., & Sperandio, V. (2016) · Nature · doi:10.1038/nature18849 · Cited by 1,420
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371
Can Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328 · cited 1×
“Neuroimaging studies support this theory, showing that reduced CBF and abnormal neurovascular coupling occurs in elderly people at the risk of AD before they show the hallmarks of the disease such as brain atrophy, cognitive impairment, or accumulation of Aβ (Smith et al., 1999; Bookheimer et al., 2000; Ruitenberg et…”
Backgroundde Leeuw, F.-E. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.9 · Cited by 1,291
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 2×
“Mouse models and in vitro studies provide further evidence of senescence in microglia (Bussian et al., 2018), endothelial cells (Broadwell, 1989), neural stem cells and possibly oligodendrocytes (Kritsilis et al.”
BackgroundResultThe role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 1×
“Chronic low-grade inflammation contributes to the increased risk of cerebrovascular disease (Lucas et al., 2006) and was shown to be a feature of the aging (Buga et al.”
BackgroundCellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270 · cited 2×
“Since aging has been linked to the accumulation of senescent cells (van Deursen, 2014; Calcinotto et al., 2019), we speculate that cellular senescence may contribute to the outcome after stroke.”
BackgroundCerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells
Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Sita, G., Racchumi, G., Ling, L., Pamer, E. G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4068 · Cited by 1,114
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · cited 1×
“The Honolulu Asia aging study demonstrated an association between elevated levels of blood pressure in middle age and vascular dementia (Launer et al., 2000).”
BackgroundMueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M. C., et al. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.2.1027-1033.2006 · Cited by 1,006
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974 · cited 1×
“, 2018), whereas dysregulation of the gastrointestinal function and colonic inflammation diminished immune competence and preceded motor symptoms in PD patients (Dobbs et al., 1999; Braak et al., 2003b; Lebouvier et al., 2009; Villaran et al., 2010; Forsyth et al., 2011).”
BackgroundArizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · cited 1×
“These proteins, which include immunoglobulins, plasmin, thrombin, and albumin, further reduce blood flow and cause vasogenic brain edema, oxidative stress, and axonal demyelination (Chen and Strickland, 1997; Mhatre et al., 2004; Farrall and Wardlaw, 2009; Chen et al., 2010).”
BackgroundCani, P. D., Osto, M., Geurts, L., & Everard, A. (2012) · Gut Microbes · doi:10.4161/gmic.19625 · Cited by 864
AMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Gouw, A. A., Seewann, A., van der Flier, W. M., Barkhof, F., Rozemuller, A. M., Scheltens, P., & Geurts, J. J. G. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204685 · Cited by 766
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Animal Model of Depression: I. Review of Evidence: Implications for Research
McKinney, W. T. (1969) · Archives of General Psychiatry · doi:10.1001/archpsyc.1969.01740200112015 · Cited by 727
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 1×
“Aβ itself is a potent vasoconstrictor (Thomas et al., 1996), worsening the hypoperfusion, which, if severe enough, directly injures neurons.”
BackgroundYin, J., Liao, S., He, Y., Wang, S., Xia, G., Liu, F., Zhu, J., You, C., Chen, Q., Zhou, L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002699 · Cited by 669
Minter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., Ward, J. F., Holtzman, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30028 · Cited by 655 · cited 1×
“, 2017) or GM partial depletion by antibiotic treatment (Minter et al., 2016) reduced the amyloid burden and microglia activation in AD transgenic mice.”
BackgroundNon-motor symptoms in Parkinson's disease
Pfeiffer, R. F. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.004 · Cited by 644
Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin
Chen, Z.-L., & Strickland, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80483-3 · Cited by 632
The bowel and beyond: The enteric nervous system in neurological disorders
Rao, M., & Gershon, M. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.107 · Cited by 629
Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model
Kamel, H., Okin, P. M., Elkind, M. S. V., & Iadecola, C. (2016) · Stroke · doi:10.1161/strokeaha.115.012004 · Cited by 627
Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
Hoyles, L., Snelling, T., Umlai, U.-K., Nicholson, J. K., Carding, S. R., Glen, R. C., & McArthur, S. (2018) · Microbiome · doi:10.1186/s40168-018-0439-y · Cited by 591
Astrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586
Animal models of neurodegenerative diseases
Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0236-8 · Cited by 576
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559 · cited 1×
“Vascular damage, initiated by vascular and genetic predisposing factors, precedes the accumulation of beta-amyloid (Aβ), which eventually leads to neurodegeneration in AD (Nelson et al., 2016).”
BackgroundUnderstanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
Ogrodnik, M., Zhu, Y., Langhi, L. G. P., Tchkonia, T., Krüger, P., Fielder, E., Victorelli, S., Ruswhandi, R. A., Giorgadze, N., Pirtskhalava, T., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.008 · Cited by 536
Microbes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532
Chinta, S. J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D. T., Campisi, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.092 · Cited by 530
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
Gram-negative bacterial molecules associate with Alzheimer disease pathology
Zhan, X., Stamova, B., Jin, L.-W., DeCarli, C., Phinney, B., & Sharp, F. R. (2016) · Neurology · doi:10.1212/wnl.0000000000003391 · Cited by 521
Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514
Translocation and dissemination of commensal bacteria in post-stroke infection
Stanley, D., Mason, L. J., Mackin, K. E., Srikhanta, Y. N., Lyras, D., Prakash, M. D., Nurgali, K., Venegas, A., Hill, M. D., Moore, R. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4194 · Cited by 464
The Gut Microbiota and Autism Spectrum Disorders
Li, Q., Han, Y., Dy, A. B. C., & Hagerman, R. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00120 · Cited by 462
Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C., Fiorini, D., Boarelli, M. C., Rossi, G., & Eleuteri, A. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02587-2 · Cited by 453
Schwann cell‐derived exosomes enhance axonal regeneration in the peripheral nervous system
Lopez‐Verrilli, M. A., Picou, F., & Court, F. A. (2013) · Glia · doi:10.1002/glia.22558 · Cited by 453
Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease
Zhang, L., Wang, Y., Xiayu, X., Shi, C., Chen, W., Song, N., Fu, X., Zhou, R., Xu, Y.-F., Huang, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170020 · Cited by 449
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Trans-Synaptic Transmission of Vesicular Wnt Signals through Evi/Wntless
Korkut, C., Ataman, B., Ramachandran, P., Ashley, J., Barria, R., Gherbesi, N., & Budnik, V. (2009) · Cell · doi:10.1016/j.cell.2009.07.051 · Cited by 443
Ridder, K., Keller, S., Dams, M., Rupp, A.-K., Schlaudraff, J., Del Turco, D., Starmann, J., Macas, J., Karpova, D., Devraj, K., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001874 · Cited by 412
Wang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2167-7 · Cited by 412
Govindarajan, N., Agis-Balboa, R. C., Walter, J., Sananbenesi, F., & Fischer, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110080 · Cited by 405
Jucker, M. (2010) · Nature Medicine · doi:10.1038/nm.2224 · Cited by 401
Hypertension and the Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Manly, J., Mayeux, R., & Luchsinger, J. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1734 · Cited by 360
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging
Scheltens, P., Barkhof, F., Leys, D., Wolters, E. C., Ravid, R., & Kamphorst, W. (1995) · Neurology · doi:10.1212/wnl.45.5.883 · Cited by 344
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333
Age-Associated Remodeling of the Intestinal Epithelial Barrier
Tran, L., & Greenwood-Van Meerveld, B. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt106 · Cited by 320
Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model
Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., & Endres, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160926 · Cited by 318
Sun, G., Li, G., Li, D., Huang, W., Zhang, R., Zhang, H., Duan, Y., & Wang, B. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.006 · Cited by 314 · cited 1×
“Peripheral neurons are responsive to EVs derived from mesenchymal stem cells and Schwann cells (Lopez-Verrilli et al., 2013, 2016; Ching et al., 2018; Sun et al., 2018; Shiue et al., 2019).”
BackgroundKreutzmann, J. C., Havekes, R., Abel, T., & Meerlo, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.053 · Cited by 309
Henskens, L. H. G., Kroon, A. A., van Oostenbrugge, R. J., Gronenschild, E. H. B. M., Fuss-Lejeune, M. M. J. J., Hofman, P. A. M., Lodder, J., & de Leeuw, P. W. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.119024 · Cited by 293
Cellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282
Association Between Atrial Fibrillation and Dementia in the General Population
de Bruijn, R. F. A. G., Heeringa, J., Wolters, F. J., Franco, O. H., Stricker, B. H. C., Hofman, A., Koudstaal, P. J., & Ikram, M. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2161 · Cited by 280
Vascular Cell Senescence Contributes to Blood–Brain Barrier Breakdown
Yamazaki, Y., Baker, D. J., Tachibana, M., Liu, C.-C., van Deursen, J. M., Brott, T. G., Bu, G., & Kanekiyo, T. (2016) · Stroke · doi:10.1161/strokeaha.115.010835 · Cited by 263
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system
Rawji, K. S., Mishra, M. K., Michaels, N. J., Rivest, S., Stys, P. K., & Yong, V. W. (2016) · Brain · doi:10.1093/brain/awv395 · Cited by 252
Regulation of Postsynaptic Retrograde Signaling by Presynaptic Exosome Release
Korkut, C., Li, Y., Koles, K., Brewer, C., Ashley, J., Yoshihara, M., & Budnik, V. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.013 · Cited by 250
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187307 · Cited by 248 · cited 1×
“Gut Microbiota Alterations in Neurodegenerative Diseases Recent reports concomitantly demonstrate a gut dysbiosis in PD (Minato et al., 2017; Wu et al., 2017), ALS, and AD patients (Cattaneo et al.”
BackgroundIrritable bowel syndrome, the microbiota and the gut-brain axis
Raskov, H., Burcharth, J., Pommergaard, H.-C., & Rosenberg, J. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1218585 · Cited by 243
Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
Tao, Q., Ang, T. F. A., DeCarli, C., Auerbach, S. H., Devine, S., Stein, T. D., Zhang, X., Massaro, J., Au, R., & Qiu, W. Q. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3597 · Cited by 239 · cited 1×
“In AD, systemic inflammation during prodromal stages shortens disease onset (Tao et al., 2018), whereas dysregulation of the gastrointestinal function and colonic inflammation diminished immune competence and preceded motor symptoms in PD patients (Dobbs et al.”
BackgroundTreatment of vascular risk factors is associated with slower decline in Alzheimer disease
Deschaintre, Y., Richard, F., Leys, D., & Pasquier, F. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b59bf3 · Cited by 232
Liu, J., Sun, J., Wang, F., Yu, X., Ling, Z., Li, H., Zhang, H., Jin, J., Chen, W., Pang, M., et al. (2015) · BioMed Research International · doi:10.1155/2015/412946 · Cited by 225
Charidimou, A., Meegahage, R., Fox, Z., Peeters, A., Vandermeeren, Y., Laloux, P., Baron, J.-C., Jager, H. R., & Werring, D. J. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304434 · Cited by 225
Pastuzyn, E. D., Day, C. E., Kearns, R. B., Kyrke-Smith, M., Taibi, A. V., McCormick, J., Yoder, N., Belnap, D. M., Erlendsson, S., Morado, D. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.024 · Cited by 213
Etiology of autistic features: the persisting neurotoxic effects of propionic acid
El-Ansary, A. K., Bacha, A. B., & Kotb, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-74 · Cited by 209
Obesity and vulnerability of the CNS
Bruce-Keller, A. J., Keller, J. N., & Morrison, C. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.004 · Cited by 200 · cited 1×
“In particular, data show that obesity is associated with cognitive decline and enhanced vulnerability to brain injury, while experimental studies in animal models confirm a profile of increased susceptibility to brain damage and decreased cognitive function (Bruce-Keller et al., 2009).”
BackgroundReduced cerebral blood flow response and compensation among patients with untreated hypertension
Jennings, J. R., Muldoon, M. F., Ryan, C., Price, J. C., Greer, P., Sutton-Tyrrell, K., van der Veen, F. M., & Meltzer, C. C. (2005) · Neurology · doi:10.1212/01.wnl.0000158283.28251.3c · Cited by 198
White, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1178 · Cited by 193
Nishihira, Y., Tan, C.-F., Onodera, O., Toyoshima, Y., Yamada, M., Morita, T., Nishizawa, M., Kakita, A., & Takahashi, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0385-z · Cited by 187 · cited 1×
“In ALS, TDP-43 is a major component of the ubiquitinated inclusions and also occurs in the neurons of the spinal ganglia (Nishihira et al., 2008).”
BackgroundBacterial Infection and Alzheimer's Disease: A Meta-Analysis
Maheshwari, P., & Eslick, G. D. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140621 · Cited by 183
Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180
Genomic integrity and the ageing brain
Chow, H.-M., & Herrup, K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4020 · Cited by 174
Topography of dilated perivascular spaces in subjects from a memory clinic cohort
Martinez-Ramirez, S., Pontes-Neto, O. M., Dumas, A. P., Auriel, E., Halpin, A., Quimby, M., Gurol, M. E., Greenberg, S. M., & Viswanathan, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f1876 · Cited by 163
DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS
Henkel, J. S., Beers, D. R., Wen, S., Bowser, R., & Appel, S. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a41228 · Cited by 153
Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
Koike, M. A., Green, K. N., Blurton-Jones, M., & LaFerla, F. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090750 · Cited by 130 · cited 1×
“The critical role of hypoperfusion is supported by the evidence that the induction of chronic global hypoperfusion in animal models causes memory impairment, the accumulation of Aβ, and synaptic dysfunction (Walsh et al., 2002; Koike et al., 2010; Wang et al., 2010).”
BackgroundHolman, C., Piper, S. K., Grittner, U., Diamantaras, A. A., Kimmelman, J., Siegerink, B., & Dirnagl, U. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002331 · Cited by 114
Changes in the Transcriptome of Human Astrocytes Accompanying Oxidative Stress-Induced Senescence
Crowe, E. P., Tuzer, F., Gregory, B. D., Donahue, G., Gosai, S. J., Cohen, J., Leung, Y. Y., Yetkin, E., Nativio, R., Wang, L.-S., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00208 · Cited by 110
Thrombin, a mediator of neurotoxicity and memory impairment
Mhatre, M., Nguyen, A., Kashani, S., Pham, T., Adesina, A., & Grammas, P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.07.007 · Cited by 105 · cited 1×
“These proteins, which include immunoglobulins, plasmin, thrombin, and albumin, further reduce blood flow and cause vasogenic brain edema, oxidative stress, and axonal demyelination (Chen and Strickland, 1997; Mhatre et al., 2004; Farrall and Wardlaw, 2009; Chen et al., 2010).”
BackgroundLittle, C. S., Joyce, T. A., Hammond, C. J., Matta, H., Cahn, D., Appelt, D. M., & Balin, B. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00304 · Cited by 71
Research works printed but not linked: 208
- Andrade, 2014, The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms., Circ. Res., 114, 1453, 10.1161/circresaha.114.303211 · DOI · Paper page
- Anselmino, 2016, Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment., Sci. Rep., 6, 10.1038/srep28635 · DOI
- Arai, 1991, Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer’s disease and control subjects., Ann. Neurol., 30, 686, 10.1002/ana.410300509 · DOI · Paper page
- Ashley, 2018, Retrovirus-like gag protein arc1 binds RNA and traffics across synaptic boutons., Cell, 172, 262, 10.1016/j.cell.2017.12.022 · DOI · Paper page
- Ask, 2018, The neuro-immuno-senescence integrative model (NISIM) on the negative association between parasympathetic activity and cellular senescence., Front. Neurosci., 12, 10.3389/fnins.2018.00726 · DOI
- Avila-Nava, 2017, Food combination based on a pre-hispanic Mexican diet decreases metabolic and cognitive abnormalities and gut microbiota dysbiosis caused by a sucrose-enriched high-fat diet in rats., Mol. Nutr. Food Res., 61, 10.1002/mntr.201501023 · doi:10.1002/mntr.201501023
- Balusu, 2016, Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles., EMBO Mol. Med., 8, 1162, 10.15252/emmm.201606271 · DOI · Paper page
- Banerjee, 2017, Stroke caused by atherosclerosis of the major intracranial arteries., Circ. Res., 120, 502, 10.1161/circresaha.116.308441 · DOI · Paper page
- Baothman, 2016, The role of gut microbiota in the development of obesity and diabetes., Lipids Health Dis., 15, 10.1186/s12944-016-0278-4 · DOI · Paper page
- Bhattacharjee, 2013, Alzheimer’s disease and the microbiome., Front. Cell Neurosci., 7, 10.3389/fncel.2013.00153 · DOI · Paper page
- Bilgel, 2019, Predicting time to dementia using a quantitative template of disease progression., Alzheimers Dement, 11, 205, 10.1016/j.dadm.2019.01.005 · DOI · Paper page
- Bloemen, 2010, Short chain fatty acids exchange: is the cirrhotic, dysfunctional liver still able to clear them?, Clin. Nutr., 29, 365, 10.1016/j.clnu.2009.10.002 · DOI
- Blum-Degen, 1995, Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?, J. Neural Transm. Suppl., 46, 139
- Bohnen, 2011, White matter lesions in Parkinson disease., Nat Rev Neurol, 7, 229, 10.1038/nrneurol.2011.21 · DOI · Paper page
- Braak, Staging of brain pathology related to sporadic Parkinson’s disease., Neurobiol. Aging, 24, 197, 10.1016/s0197-4580(02)00065-9 · DOI · Paper page
- Broadwell, 1989, Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal., Acta Neuropathol., 79, 117, 10.1007/bf00294368 · DOI · Paper page
- Brouns, 2011, Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome., Eur. Neurol., 65, 23, 10.1159/000321965 · DOI
- Brown, 2005, Neurodegenerative diseases: an overview of environmental risk factors., Environ. Health Perspect., 113, 1250, 10.1289/ehp.7567 · DOI · Paper page
- Buerge, 2011, Lobar dementia due to extreme widening of virchow-robin spaces in one hemisphere., Case Rep. Neurol., 3, 136, 10.1159/000329267 · DOI
- Buga, 2013, Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation., Biogerontology, 14, 651, 10.1007/s10522-013-9465-0 · DOI
- Campbell, 2011, Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus., Clin. Ther., 33, 511, 10.1016/j.clinthera.2011.04.015 · DOI
- Carvalho, 2012, Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochondrial abnormalities., Diabetes Metab. Res. Rev., 61, 1234, 10.2337/db11-1186 · DOI · Paper page
- Caviedes, 2017, Endothelial nitric oxide synthase is present in dendritic spines of neurons in primary cultures., Front. Cell Neurosci., 11, 10.3389/fncel.2017.00180 · DOI
- Chalazonitis, 2018, Enteric nervous system manifestations of neurodegenerative disease., Brain Res., 1693, 207, 10.1016/j.brainres.2018.01.011 · DOI · Paper page
- Chao, 2009, Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease., J. Neuroimmunol., 216, 39, 10.1016/j.jneuroim.2009.09.003 · DOI
- Charidimou, 2014, White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?, Neurology, 82, 57, 10.1212/01.wnl.0000438225.02729.04 · DOI · Paper page
- Chen, 2010, Thrombin mediates severe neurovascular injury during ischemia., Stroke, 41, 2348, 10.1161/strokeaha.110.584920 · DOI · Paper page
- Ching, 2018, Schwann cell-like differentiated adipose stem cells promote neurite outgrowth via secreted exosomes and RNA transfer., Stem Cell Res. Ther., 9, 10.1186/s13287-018-1017-8 · DOI
- Choi, 2011, Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model., Stroke, 42, 2595, 10.1161/strokeaha.111.620179 · DOI · Paper page
- Cole, 2019, Brain age and other bodily ’ages’: implications for neuropsychiatry., Mol. Psychiatry, 24, 266, 10.1038/s41380-018-0098-1 · DOI · Paper page
- Cole, 2006, Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease., Brain, 129, 2957, 10.1093/brain/awl228 · DOI · Paper page
- Collins, 2012, Parasympathetic autonomic dysfunction is common in mild cognitive impairment., Neurobiol. Aging, 33, 2324, 10.1016/j.neurobiolaging.2011.11.017 · DOI
- Collins, 2013, Gut microbiota: intestinal bacteria influence brain activity in healthy humans., Nat. Rev. Gastroenterol. Hepatol., 10, 326, 10.1038/nrgastro.2013.76 · DOI
- Conte, 2013, Pathophysiology of somatosensory abnormalities in Parkinson disease., Nat. Rev. Neurol., 9, 687, 10.1038/nrneurol.2013.224 · DOI · Paper page
- Coon, 2018, Neuropathology of autonomic dysfunction in synucleinopathies., Mov. Disord., 33, 349, 10.1002/mds.27186 · DOI · Paper page
- Cordonnier, 2011, Brain microbleeds: more evidence, but still a clinical dilemma., Curr. Opin. Neurol., 24, 69, 10.1097/wco.0b013e328341f8c0 · DOI · Paper page
- Coulter, 2018, The ESCRT-III protein CHMP1A mediates secretion of sonic hedgehog on a distinctive subtype of extracellular vesicles., Cell Rep., 24, 973, 10.1016/j.celrep.2018.06.100 · DOI
- Crous-Bou, 2017, Alzheimer’s disease prevention: from risk factors to early intervention., Alzheimers Res. Ther., 9, 10.1186/s13195-017-0297-z · DOI · Paper page
- Dabby, 2006, Skin biopsy for assessment of autonomic denervation in Parkinson’s disease., J. Neural Transm., 113, 1169, 10.1007/s00702-005-0431-0 · DOI
- Dalle Pezze, 2014, Dynamic modelling of pathways to cellular senescence reveals strategies for targeted interventions., PLoS Comput. Biol., 10, 10.1371/journal.pcbi.1003728 · DOI · Paper page
- Davaapil, 2017, Conserved and novel functions of programmed cellular senescence during vertebrate development., Development, 144, 106, 10.1242/dev.138222 · DOI · Paper page
- Dearborn, 2017, Intracranial atherosclerosis and dementia: the atherosclerosis risk in communities (ARIC) study., Neurology, 88, 1556, 10.1212/wnl.0000000000003837 · DOI
- Dickinson, 2001, Why are strokes related to hypertension? Classic studies and hypotheses revisited., J. Hypertens., 19, 1515, 10.1097/00004872-200109000-00001 · DOI
- Dietzel, 2018, Does atrial fibrillation cause cognitive decline and dementia?, Europace, 20, 408, 10.1093/europace/eux031 · DOI
- Dirnagl, 1997, Metabolic aspects of neurovascular coupling., Adv. Exp. Med. Biol., 413, 155, 10.1007/978-1-4899-0056-2_17 · DOI
- Dobbs, 1999, Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism., Acta Neurol. Scand., 100, 34, 10.1111/j.1600-0404.1999.tb00721.x · DOI · Paper page
- Dolan, 2010, Atherosclerosis, dementia, and Alzheimer disease in the baltimore longitudinal study of aging cohort., Ann. Neurol., 68, 231, 10.1002/ana.22055 · DOI · Paper page
- Doty, 2017, Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?, Lancet Neurol., 16, 478, 10.1016/s1474-4422(17)30123-0 · DOI · Paper page
- Driver-Dunckley, 2014, Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease., Parkinsonism Relat. Disord., 20, 1260, 10.1016/j.parkreldis.2014.08.006 · DOI
- Duarte, 2013, Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration., Biochim. Biophys. Acta, 1832, 527, 10.1016/j.bbadis.2013.01.008 · DOI
- Duarte, 2012, Insulin in central nervous system: more than just a peripheral hormone., J. Aging Res., 2012, 10.1155/2012/384017 · DOI · Paper page
- Duda, 1999, The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases., Exp. Neurol., 160, 515, 10.1006/exnr.1999.7228 · DOI · Paper page
- Duran-Vilaregut, 2009, Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid., Neurotoxicology, 30, 136, 10.1016/j.neuro.2008.10.007 · DOI
- Eberle, 2012, Diabetic and metabolic programming: mechanisms altering the intrauterine milieu., ISRN Pediatr., 2012, 10.5402/2012/975685 · DOI
- Fan, 2017, Mechanisms of hippocampal aging and the potential for rejuvenation., Annu. Rev. Neurosci., 40, 251, 10.1146/annurev-neuro-072116-031357 · DOI · Paper page
- Faraci, 1998, Regulation of the cerebral circulation: role of endothelium and potassium channels., Physiol. Rev., 78, 53, 10.1152/physrev.1998.78.1.53 · DOI · Paper page
- Fevrier, 2004, Cells release prions in association with exosomes., Proc. Natl. Acad. Sci. U.S.A., 101, 9683, 10.1073/pnas.0308413101 · DOI · Paper page
- Figueira, 2016, NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls., Mol. Biosyst., 12, 2562, 10.1039/c6mb00233a · DOI · Paper page
- Fleitas, 2018, proBDNF is modified by advanced glycation end products in Alzheimer’s disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing., Mol. Brain, 11, 10.1186/s13041-018-0411-6 · DOI · Paper page
- Gan, 2018, Converging pathways in neurodegeneration, from genetics to mechanisms., Nat. Neurosci., 21, 1300, 10.1038/s41593-018-0237-7 · DOI · Paper page
- Gariepy, 2011, Obesity and the risk of disability in a 12-year cohort study: the role of psychological distress., Soc. Psychiatry Psychiatr. Epidemiol., 46, 1173, 10.1007/s00127-010-0284-1 · DOI
- Garner, 2017, Introducing therioepistemology: the study of how knowledge is gained from animal research., Lab Anim., 46, 103, 10.1038/laban.1224 · DOI
- Gensollen, 2016, How colonization by microbiota in early life shapes the immune system., Science, 352, 539, 10.1126/science.aad9378 · DOI · Paper page
- Girouard, 2006, Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease., J. Appl. Physiol., 100, 328, 10.1152/japplphysiol.00966.2005 · DOI · Paper page
- Gitler, 2017, Neurodegenerative disease: models, mechanisms, and a new hope., Dis. Model Mech., 10, 499, 10.1242/dmm.030205 · DOI · Paper page
- Graves, 2017, Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin., Am. Heart J., 188, 93, 10.1016/j.ahj.2017.02.026 · doi:10.1016/j.ahj.2017.02.026
- Grey, 2015, Acceleration of alpha-synuclein aggregation by exosomes., J. Biol. Chem., 290, 2969, 10.1074/jbc.m114.585703 · DOI · Paper page
- Grunert, 2013, Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients., Orphanet J. Rare Dis., 8, 10.1186/1750-1172-8-6 · DOI · Paper page
- Gutierrez Becker, 2018, Gaussian process uncertainty in age estimation as a measure of brain abnormality., Neuroimage, 175, 246, 10.1016/j.neuroimage.2018.03.075 · DOI · Paper page
- Hallene, 2006, Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations., Neuroscience, 142, 267, 10.1016/j.neuroscience.2006.06.017 · DOI
- Helzner, 2009, Contribution of vascular risk factors to the progression in Alzheimer disease., Arch. Neurol., 66, 343, 10.1001/archneur.66.3.343 · DOI · Paper page
- Hill, 2015, Microbial-generated amyloids and Alzheimer’s disease (AD)., Front. Aging Neurosci., 7, 10.3389/fnagi.2015.00009 · DOI · Paper page
- Hofman, 1997, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the rotterdam Study., Lancet, 349, 151, 10.1016/s0140-6736(96)09328-2 · DOI · Paper page
- Holm, 2018, Extracellular vesicles: multimodal envoys in neural maintenance and repair., Trends Neurosci., 41, 360, 10.1016/j.tins.2018.03.006 · DOI · Paper page
- Houlden, 2016, Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production., Brain Behav. Immun., 57, 10, 10.1016/j.bbi.2016.04.003 · DOI · Paper page
- Howitt, 2016, Exosomes in the pathology of neurodegenerative diseases., J. Biol. Chem., 291, 26589, 10.1074/jbc.r116.757955 · DOI · Paper page
- Hryhorczuk, 2013, Metabolic disturbances connecting obesity and depression., Front. Neurosci., 7, 10.3389/fnins.2013.00177 · DOI · Paper page
- Hsu, 2017, Primary and secondary prevention trials in Alzheimer disease: looking back, Moving Forward., Curr. Alzheimer Res., 14, 426, 10.2174/1567205013666160930112125 · DOI · Paper page
- Hufeldt, 2010, Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors., Comp. Med., 60, 336
- Iadecola, 2013, The pathobiology of vascular dementia., Neuron, 80, 844, 10.1016/j.neuron.2013.10.008 · DOI · Paper page
- Idiaquez, 2011, Autonomic dysfunction in neurodegenerative dementias., J. Neurol. Sci., 305, 22, 10.1016/j.jns.2011.02.033 · DOI
- 2002, Constitution of the World Health Organization. 1946., Bull. World Health Organ, 80, 983
- Jellinger, 2010, Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases., Neurodegener. Dis., 7, 112, 10.1159/000285518 · DOI · Paper page
- Jia, 2018, Exosomes derived from high-glucose-stimulated schwann cells promote development of diabetic peripheral neuropathy., FASEB J, 10.1096/fj.201800597R · DOI
- Joachim, 1989, Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease., Nature, 341, 226, 10.1038/341226a0 · DOI · Paper page
- Kalaria, 2010, Vascular basis for brain degeneration: faltering controls and risk factors for dementia., Nutr. Rev., S74, 10.1111/j.1753-4887.2010.00352.x · DOI · Paper page
- Kim, 2018, Distinct amyloid precursor protein processing machineries of the olfactory system., Biochem. Biophys. Res. Commun., 495, 533, 10.1016/j.bbrc.2017.10.153 · DOI
- Kim, 2016, Vasculo-neuronal coupling: retrograde vascular communication to brain neurons., J. Neurosci., 36, 12624, 10.1523/jneurosci.1300-16.2016 · DOI · Paper page
- Klein, 2017, Prevention of epilepsy: should we be avoiding clinical trials?, Epilepsy Behav, 72, 188, 10.1016/j.yebeh.2017.05.024 · DOI
- Koles, 2012, Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons., J. Biol. Chem., 287, 16820, 10.1074/jbc.m112.342667 · DOI · Paper page
- Korhonen, 2018, 3D human brain cell models: new frontiers in disease understanding and drug discovery for neurodegenerative diseases., Neurochem. Int., 120, 191, 10.1016/j.neuint.2018.08.012 · DOI
- Kountouras, 2009, Eradication of helicobacter pylori may be beneficial in the management of Alzheimer’s disease., J. Neurol., 256, 758, 10.1007/s00415-009-5011-z · DOI · Paper page
- Kupsky, 1987, Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells., Neurology, 37, 1253, 10.1212/WNL.37.7.1253 · DOI · Paper page
- Lachenal, 2011, Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity., Mol. Cell. Neurosci., 46, 409, 10.1016/j.mcn.2010.11.004 · DOI · Paper page
- Larsson, 2018, Does treating vascular risk factors prevent dementia and Alzheimer’s disease? a systematic review and meta-analysis., J. Alzheimers Dis., 64, 657, 10.3233/jad-180288 · DOI · Paper page
- Lebouvier, 2009, The second brain and Parkinson’s disease., Eur. J. Neurosci., 30, 735, 10.1111/j.1460-9568.2009.06873.x · DOI · Paper page
- Lee, 2017, Medical big data: promise and challenges., Kidney Res. Clin. Pract., 36, 3, 10.23876/j.krcp.2017.36.1.3 · DOI · Paper page
- Lee, 2014, Synergistic effects of ischemia and beta-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment., JAMA Psychiatry, 71, 412, 10.1001/jamapsychiatry.2013.4506 · DOI · Paper page
- Lee, 2018, Reciprocal control of excitatory synapse numbers by Wnt and Wnt inhibitor PRR7 secreted on exosomes., Nat. Commun., 9, 10.1038/s41467-018-05858-2 · DOI · Paper page
- Lema Tome, 2013, Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease–is there a link?, Mol. Neurobiol, 47, 561, 10.1007/s12035-012-8267-8 · DOI · Paper page
- Li, 2017, Gut microbiota and atherosclerosis., Curr. Atheroscler. Rep., 19, 10.1007/s11883-017-0675-9 · DOI
- Li, 2018, In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation., J. Neuroinflammation, 15, 10.1186/s12974-017-1038-8 · DOI · Paper page
- Li, 1991, Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells., Cancer Res., 51, 2531
- Liddell, 2017, Are astrocytes the predominant cell type for activation of nrf2 in aging and neurodegeneration?, Antioxidants, 6, 10.3390/antiox6030065 · DOI · Paper page
- Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010., Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8 · DOI · Paper page
- Lloret-Villas, 2017, The impact of mathematical modeling in understanding the mechanisms underlying neurodegeneration: evolving dimensions and future directions., CPT Pharmacometrics Syst. Pharmacol., 6, 73, 10.1002/psp4.12155 · DOI
- Lopez-Verrilli, 2016, Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth., Neuroscience, 320, 129, 10.1016/j.neuroscience.2016.01.061 · DOI · Paper page
- Lusis, 2000, Atherosclerosis., Nature, 407, 233, 10.1038/35025203 · DOI · Paper page
- Maldonado, 2016, Lipopolysaccharide modification in Gram-negative bacteria during chronic infection., FEMS Microbiol. Rev., 40, 480, 10.1093/femsre/fuw007 · DOI · Paper page
- Manwani, 2013, Differential effects of aging and sex on stroke induced inflammation across the lifespan., Exp. Neurol., 249, 120, 10.1016/j.expneurol.2013.08.011 · DOI · Paper page
- Marin, 2018, Olfactory dysfunction in neurodegenerative diseases., Curr. Allergy Asthma Rep., 18, 10.1007/s11882-018-0796-4 · DOI · Paper page
- Mattson, 1999, Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases., Ann. N. Y. Acad. Sci., 893, 154, 10.1111/j.1749-6632.1999.tb07824.x · DOI · Paper page
- Mergenthaler, 2004, Pathophysiology of stroke: lessons from animal models., Metab. Brain Dis., 19, 151, 10.1023/b:mebr.0000043966.46964.e6 · DOI · Paper page
- Mergenthaler, 2012, Do stroke models model stroke?, Dis Model Mech, 5, 718, 10.1242/dmm.010033 · DOI
- Mills, 2007, Biomarkers of cerebrovascular disease in dementia., Br. J. Radiol., 2, S128, 10.1259/bjr/79217686 · DOI · Paper page
- Minamiyama, 2004, Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy., Hum. Mol. Genet., 13, 1183, 10.1093/hmg/ddh131 · DOI · Paper page
- Mondadori, 2006, Enhanced brain activity may precede the diagnosis of Alzheimer’s disease by 30 years., Brain, 129, 2908, 10.1093/brain/awl266 · DOI · Paper page
- Moore, 2008, The hemo-neural hypothesis: on the role of blood flow in information processing., J. Neurophysiol., 99, 2035, 10.1152/jn.01366.2006 · DOI · Paper page
- Morsi, 2018, A shared comparison of diabetes mellitus and neurodegenerative disorders., J. Cell Biochem., 119, 1249, 10.1002/jcb.26261 · DOI · Paper page
- Mukherjee, 2019, A microglial signature directing human aging and neurodegeneration-related gene networks., Front. Neurosci., 13, 10.3389/fnins.2019.00002 · DOI · Paper page
- Nishtala, 2018, Atrial fibrillation and cognitive decline in the framingham heart study., Heart Rhythm, 15, 166, 10.1016/j.hrthm.2017.09.036 · DOI · Paper page
- Nolano, 2008, Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation., Brain, 131, 1903, 10.1093/brain/awn102 · DOI · Paper page
- Olufadi, 2008, Clinical and laboratory diagnosis of the metabolic syndrome., J. Clin. Pathol., 61, 697, 10.1136/jcp.2007.048363 · DOI · Paper page
- Oost, 2018, Targeting senescence to delay progression of multiple sclerosis., J. Mol. Med., 96, 1153, 10.1007/s00109-018-1686-x · DOI
- Org, 2017, Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort., Genome Biol., 18, 10.1186/s13059-017-1194-2 · DOI · Paper page
- Orimo, 2005, Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2., Mov. Disord., 20, 1350, 10.1002/mds.20594 · DOI
- Orock, 2019, Age-related cognitive impairment: role of reduced synaptobrevin-2 levels in memory and synaptic plasticity deficits., J. Gerontol. A Biol. Sci. Med. Sci., 10.1093/gerona/glz013 · DOI
- Ozkor, 2011, Endothelium-derived hyperpolarizing factor and vascular function., Cardiol. Res. Pract., 2011, 10.4061/2011/156146 · DOI
- Park, 2017, Metagenome analysis of bodily microbiota in a mouse model of Alzheimer disease using bacteria-derived membrane vesicles in blood., Exp. Neurobiol., 26, 369, 10.5607/en.2017.26.6.369 · DOI · Paper page
- Pellegrinelli, 2018, Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue., Nat. Commun., 9, 10.1038/s41467-018-07453-x · DOI
- Percie du Sert, 2017, The improve guidelines (Ischaemia models: procedural refinements of in vivo experiments)., J. Cereb. Blood Flow Metab., 37, 3488, 10.1177/0271678x17709185 · DOI · Paper page
- Petcu, 2008, Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review., Gerontology, 54, 6, 10.1159/000112845 · DOI
- Poels, 2012, Arterial stiffness and cerebral small vessel disease: the rotterdam scan study., Stroke, 43, 2637, 10.1161/strokeaha.111.642264 · DOI · Paper page
- Polanco, 2016, Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner., J. Biol. Chem., 291, 12445, 10.1074/jbc.m115.709485 · DOI · Paper page
- Popa-Wagner, 2011, Perturbed cellular response to brain injury during aging., Ageing Res. Rev., 10, 71, 10.1016/j.arr.2009.10.008 · DOI
- Popa-Wagner, 2007, The response of the aged brain to stroke: too much, too soon?, Curr. Neurovasc. Res, 4, 216, 10.2174/156720207781387213 · DOI · Paper page
- Popa-Wagner, 2010, Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents., Curr. Neurovasc. Res., 7, 251, 10.2174/156720210792231813 · DOI
- Postuma, 2015, REM sleep behavior disorder and neuropathology in Parkinson’s disease., Mov. Disord., 30, 1413, 10.1002/mds.26347 · DOI · Paper page
- Przedborski, 2003, Neurodegeneration: what is it and where are we?, J. Clin. Invest., 111, 3, 10.1172/JCI200317522 · DOI · Paper page
- Purves, 1988, Body and Brain: A Trophic Theory of Neural Connections.
- Qureshi, 2013, Towards a ’systems’-level understanding of the nervous system and its disorders., Trends Neurosci., 36, 674, 10.1016/j.tins.2013.07.003 · DOI · Paper page
- Racosta, 2015, Autonomic dysfunction in multiple sclerosis., Auton. Neurosci., 193, 1, 10.1016/j.autneu.2015.06.001 · DOI
- Ramirez, 2015, Visible virchow-robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the sunnybrook dementia study., J. Alzheimers. Dis., 43, 415, 10.3233/jad-132528 · DOI · Paper page
- Ransohoff, 2018, All (animal) models (of neurodegeneration) are wrong. Are they also useful?, J. Exp. Med., 215, 2955, 10.1084/jem.20182042 · DOI · Paper page
- Reichling, 2011, Pain and death: neurodegenerative disease mechanisms in the nociceptor., Ann. Neurol., 69, 13, 10.1002/ana.22351 · DOI
- Rios-Covian, 2016, Intestinal short chain fatty acids and their link with diet and human health., Front. Microbiol., 7, 10.3389/fmicb.2016.00185 · DOI · Paper page
- Ritzel, 2018, Aging alters the immunological response to ischemic stroke., Acta Neuropathol., 136, 89, 10.1007/s00401-018-1859-2 · DOI · Paper page
- Robbins, 2017, Human induced pluripotent stem cells as a research tool in Alzheimer’s disease., Psychol. Med., 47, 2587, 10.1017/s0033291717002124 · DOI
- Roberts, 2018, The human brain microbiome; there are bacteria in our brains!, Conference Report at the Society for Neuroscience Meeting
- Rogers, 1984, Senescent microstructural changes in rat cerebellum., Brain Res., 292, 23, 10.1016/0006-8993(84)90886-2 · DOI
- Roquer, 2009, Endothelial dysfunction, vascular disease and stroke: the ARTICO study., Cerebrovasc. Dis., 25, 10.1159/000200439 · DOI
- Roriz-Filho, 2009, (Pre)diabetes, brain aging, and cognition., Biochim. Biophys. Acta, 1792, 432, 10.1016/j.bbadis.2008.12.003 · DOI · Paper page
- Roy, 1890, On the regulation of the blood-supply of the brain., J. Physiol., 11, 85, 10.1113/jphysiol.1890.sp000321 · DOI · Paper page
- Ryden, 2019, Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke., J. Intern. Med., 286, 101, 10.1111/joim.12902 · DOI
- Sadoshima, 1983, Mechanisms of protection against stroke in stroke-prone spontaneously hypertensive rats., Am. J. Physiol., 244, H406
- Saha, 2000, Induction of neuronal death by alpha-synuclein., Eur. J. Neurosci., 12, 3073, 10.1046/j.1460-9568.2000.00210.x · DOI · Paper page
- Sanchez-Tapia, 2017, Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet., Sci. Rep., 7, 10.1038/s41598-017-05096-4 · DOI
- Sanguinetti, 2018, Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet., Sci. Rep., 8, 10.1038/s41598-018-23261-1 · DOI · Paper page
- Schmidt, 1994, NO at work., Cell, 78, 919, 10.1016/0092-8674(94)90267-4 · DOI · Paper page
- Seib, 2015, Neurogenesis in the normal ageing hippocampus: a mini-review., Gerontology, 61, 327, 10.1159/000368575 · DOI
- Selvarajah, 2009, Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of stroke., Eur. Radiol., 19, 1011, 10.1007/s00330-008-1202-8 · DOI
- Shankle, 1993, Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease., Mod. Pathol., 6, 10
- Shen, 2017, Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state., J. Alzheimers. Dis., 56, 385, 10.3233/jad-160884 · DOI · Paper page
- Shiue, 2019, Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury-induced pain in rats., Pain, 160, 210, 10.1097/j.pain.0000000000001395 · DOI · Paper page
- Silvestrini, 2006, Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease., Stroke, 37, 1010, 10.1161/01.str.0000206439.62025.97 · DOI · Paper page
- Simeoli, 2017, Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma., Nat. Commun., 8, 10.1038/s41467-017-01841-5 · DOI · Paper page
- Singh, 2016, Microbiota dysbiosis controls the neuroinflammatory response after stroke., J. Neurosci., 36, 7428, 10.1523/jneurosci.1114-16.2016 · DOI · Paper page
- Singh, 2018, The gut microbiome primes a cerebroprotective immune response after stroke., J. Cereb. Blood Flow Metab., 38, 1293, 10.1177/0271678x18780130 · DOI · Paper page
- Smith, 1999, Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease., Neurology, 53, 1391, 10.1212/WNL.53.7.1391 · DOI · Paper page
- Snowdon, 1997, Brain infarction and the clinical expression of Alzheimer disease. The nun study., JAMA, 277, 813, 10.1001/jama.277.10.813 · doi:10.1001/jama.277.10.813 · Paper page
- Song, 2007, Clinical significance of silent cerebral infarctions in patients with Alzheimer disease., Cogn. Behav. Neurol., 20, 93, 10.1097/wnn.0b013e31805d859e · DOI · Paper page
- Stanley, 2018, An insight into intestinal mucosal microbiota disruption after stroke., Sci. Rep., 8, 10.1038/s41598-017-18904-8 · DOI · Paper page
- Syeda, 2018, Bioactive food abates metabolic and synaptic alterations by modulation of gut microbiota in a mouse model of Alzheimer’s disease., J. Alzheimers. Dis., 66, 1657, 10.3233/jad-180556 · DOI · Paper page
- Szablewski, 2018, Human gut microbiota in health and Alzheimer’s disease., J. Alzheimers. Dis., 62, 549, 10.3233/jad-170908 · DOI · Paper page
- Taguchi, 2016, Brain region-dependent differential expression of alpha-synuclein., J. Comp. Neurol., 524, 1236, 10.1002/cne.23901 · DOI · Paper page
- Thery, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines., J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750 · DOI · Paper page
- Tian, 2014, Endothelial cell senescence and age-related vascular diseases., J. Genet. Genom., 41, 485, 10.1016/j.jgg.2014.08.001 · DOI
- Toledo, 2013, Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the national Alzheimer’s coordinating centre., Brain, 136, 2697, 10.1093/brain/awt188 · DOI · Paper page
- Torres-Fuentes, 2017, The microbiota-gut-brain axis in obesity., Lancet Gastroenterol. Hepatol., 2, 747, 10.1016/S2468-1253(17)30147-4 · DOI · Paper page
- Turnquist, 2016, p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration., Cell Death. Differ., 23, 1515, 10.1038/cdd.2016.37 · DOI · Paper page
- van Oijen, 2007, Atherosclerosis and risk for dementia., Ann. Neurol., 61, 403, 10.1002/ana.21073 · DOI · Paper page
- VanGuilder, 2010, Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome., J. Neurochem., 113, 1577, 10.1111/j.1471-4159.2010.06719.x · DOI · Paper page
- Verdu, 2015, Novel players in coeliac disease pathogenesis: role of the gut microbiota., Nat. Rev. Gastroenterol. Hepatol., 12, 497, 10.1038/nrgastro.2015.90 · DOI · Paper page
- Vicente Miranda, 2016, Glycation in Parkinson’s disease and Alzheimer’s disease., Mov. Disord., 31, 782, 10.1002/mds.26566 · DOI
- Villaran, 2010, Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson‘s disease., J. Neurochem., 114, 1687, 10.1111/j.1471-4159.2010.06879.x · DOI · Paper page
- Villringer, 1997, Understanding functional neuroimaging methods based on neurovascular coupling., Adv. Exp. Med. Biol., 413, 177, 10.1007/978-1-4899-0056-2_20 · DOI
- Wakabayashi, 2010, Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain., Acta Neuropathol., 120, 1, 10.1007/s00401-010-0706-x · DOI · Paper page
- Wakabayashi, 1990, Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system., Acta Neuropathol., 79, 581, 10.1007/bf00294234 · DOI · Paper page
- Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo., Nature, 416, 535, 10.1038/416535a · DOI · Paper page
- Walton, 2019, Unknown fates of (brain) oxidation or UFO: close encounters with neuronal senescence., Free Radic Biol. Med., 134, 695, 10.1016/j.freeradbiomed.2019.01.012 · DOI · Paper page
- Wang, 2007, Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats., Neuroscience, 149, 739, 10.1016/j.neuroscience.2007.07.065 · DOI
- Wang, 2010, Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization in rats., J. Alzheimers Dis., 21, 813, 10.3233/jad-2010-100216 · DOI · Paper page
- Wardlaw, 2013, Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration., Lancet Neurol., 12, 822, 10.1016/S1474-4422(13)70124-8 · DOI · Paper page
- Wendell, 2012, Carotid atherosclerosis and prospective risk of dementia., Stroke, 43, 3319, 10.1161/strokeaha.112.672527 · DOI · Paper page
- Wenk, 2000, Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat., Brain Res., 885, 1, 10.1016/s0006-8993(00)02792-x · DOI
- Willner, 1984, The validity of animal models of depression., Psychopharmacology, 83, 1, 10.1007/bf00427414 · DOI · Paper page
- Winek, 2016, Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke., Stroke, 47, 1354, 10.1161/strokeaha.115.011800 · DOI · Paper page
- Wittko-Schneider, 2014, Cerebral angiogenesis during development: who is conducting the orchestra?, Methods Mol. Biol., 1135, 3, 10.1007/978-1-4939-0320-7_1 · DOI
- Wong, 1995, Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation., Adv. Pharmacol., 34, 155, 10.1016/s1054-3589(08)61084-4 · DOI
- Wu, 2017, Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in drosophila., Nat. Commun., 8, 10.1038/s41467-017-00040-6 · DOI · Paper page
200 of 208 shown
Cited by
Cano, A., Sánchez-López, E., Ettcheto, M., López-Machado, A., Espina, M., Souto, E. B., Galindo, R., Camins, A., García, M. L., & Turowski, P. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0443 · Cited by 144
Jia, W., Rajani, C., Kaddurah‐Daouk, R., & Li, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21653 · Cited by 88
“Nevertheless, it should be noted that strong variations have been observed in terms of the relationship between gut microbial diversity and AD either in patients or mice models, which is extensively reviewed by Castillo et al recently.(40) There are many variables that may exert dramatic impacts on the consistency of…”
BackgroundLiu, X., Shen, L., Wan, M., Xie, H., & Wang, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02428-1 · Cited by 33
“…between the peripheral environment and the brain is emerging as a significant factor in the etio-pathogenesis of NDDs. Peripheral cells have been shown to secrete exogenous toxic protein species that can spread to the CNS, potentially instigating or exacerbating neurodegenerative cascades [14].”
Background
Metadata
- Authors
- Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., Pérez-Velázquez, J., Piña, A. L., Rubio, K., García, H. P. S., Syeda, T., Vanoye-Carlo, A., Villringer, A., Winek, K., & Zille, M.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-07-24
- Volume
- 13
- Pages
- 728-728
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2963701142
- Cited by
- 79
- References
- 127
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Bundesministerium für Bildung und Forschung
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.